Screening of Drugs to Treat 8p11 Myeloproliferative Syndrome Using Patient-Derived Induced Pluripotent Stem Cells with Fusion Gene CEP110-FGFR1

Induced pluripotent stem (iPS) cells provide powerful tools for studying disease mechanisms and developing therapies for diseases. The 8p11 myeloproliferative syndrome (EMS) is an aggressive chronic myeloproliferative disorder (MPD) that is caused by constitutive activation of fibroblast growth fact...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Yamamoto, Shohei, Otsu, Makoto, Matsuzaka, Emiko, Konishi, Chieko, Takagi, Haruna, Hanada, Sachiyo, Mochizuki, Shinji, Nakauchi, Hiromitsu, Imai, Kohzoh, Tsuji, Kohichiro, Ebihara, Yasuhiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372437/
https://ncbi.nlm.nih.gov/pubmed/25803811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120841
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia